Navigation Links
IMA wants members not to do sex determination tests during pregnancy

The Indian Medical Association has asked its members to refrain from conducting sex-determination tests and aiding female foeticide. No support would be extended to practitioners caught in the act, the IMA said on Sunday. "We as an organisation should warn our members against aiding in such heinous crimes", said Dr. Vinay Agarwal, joint secretary, IMA headquarters, New Delhi.

He was speaking at a regional workshop on female foeticide and infanticide organised by the IMA, Tambaram, with support from the IMA headquarters and the UNICEF here.

Dr. P. K. Kesavan, IMA State president, said the organisation was concerned over the issue and was committed to rooting out female foeticide. The IMA and non-governmental organisations should work in cooperation with each other and a continuous monitoring and reporting mechanism should be evolved. Dr. Ketan Desai, IMA national president, said an awareness drive should be launched to prevent female foeticide and infanticide.

Mr. L. K. Tripathy, Health Secretary, pointed to three indicators in the census 2001 and said the situation in the State had improved compared to the previous decade.

Ms. Sabitha Naqvi, from UNICEF, New Delhi, stressed the importance of roping celebrities and film personalities into the anti-foeticide campaign. Mrs. Latha Rajanikanth, correspondent, Ashram School, Chennai, lighted a traditional lamp to mark the inauguration. Dr. Sheela Ramani, treasurer, IMA, Tambaram, Dr. Sanjeev Malik, secretary, IMA, New Delhi, Dr. M. Balasubramanian, programme coordinator, and Mr. Thomas George, from UNICEF, Chennai, highlighted various aspects of the problem.

Courtesy : The Hindu
'"/>




Page: 1

Related medicine news :

1. Students wants to extent Tution waiver in Ontario
2. Catherine Zeta wants to give up nicotine cravings
3. Invest on gym memberships
4. Religious Leaders condemn determination of sex in hospitals
5. Doctors advice early anemia tests
6. Genetic tests for cancer
7. Space research leads to needle-free blood tests
8. Early diagnosis for autism from blood tests may be possible
9. Skin tests confirms cancer
10. Genetically modified rice faces strong protests in Asia
11. Child specific HIV drugs and laboratory tests should be developed
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/18/2017)... ... ... Delaware farmer Rick Dickerson attended the 2017 Soybean Leadership College ... a thousand acres of soybeans, corn and wheat, and raises peas, sweet corn, baby ... for the fresh market. He also operates a roadside stand and raises broilers for ...
(Date:1/18/2017)... FORT LAUDERDALE, FL (PRWEB) , ... January 18, ... ... and how to manage it from the number one doctor-recommended OTC antiperspirant, Certain ... population and often go untreated. , Certain Dri created this infographic to explain ...
(Date:1/18/2017)... ARBOR, Mich. USA; SAN JOSE, Calif, USA; and SHANGHAI, China ... ... (PRWEB) January 18, 2017 -- Global public health ... to reduce arsenic V (pentavalent arsenic) to NSF/ANSI 53: Drinking ... for drinking water treatment units. This certification verifies that MicroCeramics’ ...
(Date:1/18/2017)... ... January 18, 2017 , ... The V Foundation for Cancer Research, ... official endurance training and fundraising team, to compete in the Boston Marathon on April ... to finish the world’s oldest annual marathon to join Team V and support the ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... announce that their Vice President of Franchise Development, Paula Turner Pizarro, was recently ... business program, which features the insights of top business leaders from across the ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... SUNNYVALE, Calif. , Jan. 19, 2017 ... that its CyberKnife® and TomoTherapy® Systems continue to set ... systems received the highest composite overall user satisfaction rating ... to the Q4 2016 MD Buyline Market Intelligence Briefing™. ... achieved the highest composite ratings among industry peers for ...
(Date:1/19/2017)... January 19, 2017 Shire plc ... the U.S. Food and Drug Administration (FDA) has acknowledged ... Drug Application (NDA) for SHP465, a long-acting, triple-bead, mixed ... potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA ... June 20, 2017, the designated Prescription Drug User Fee ...
(Date:1/19/2017)... SAN FRANCISCO , January 19, 2017 The global  ... a new report by Grand View Research, Inc. The heightening prevalence of cardiac ... governing the growth of Pacemaker globally. In addition, technological enhancements in these devices ... Reading ... Grand View Research Logo ...
Breaking Medicine Technology: